June 1, 2022 | Portfolio News

Moxe Health Raises $30M Series B to Further Advance Interoperability

22

Novel FDA PMA & de novo 510k approvals

61

U.S. Commercial Product Launches

40

Level I Clinical Trials

34

Strategic Financings

32

Exits by IPO or M&A